Dudu Duygu Civan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dudu Duygu Civan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Aygen Yilmaz
Department of Pediatric Gastroenterology, Akdeniz University, Antalya, Turkey
2 shared publications - Hatice Yilmaz Dagli
Department of Pediatric Gastroenterology Akdeniz University Antalya Turkey
2 shared publications - Reha Artan
Department of Pediatric Gastroenterology, Akdeniz University, Antalya, Turkey
2 shared publications - Alper Köker
Division of Pediatric Critical Care, Department of Pediatrics, Akdeniz University Faculty of Medicine, Antalya, Turkiye
1 shared publication - Erdem Çebişli
Department of Pediatric Intensive Care University of Health Sciences, Antalya Training and Research Hospital Antalya Turkey
1 shared publication - Filiz Ekici
Department of Pediatric Cardiology, Akdeniz University Faculty of Medicine, Antalya, Turkey
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (5) , 1462-1469
Lactulose hydrogen breath test findings in children and adolescents with duodenogastric reflux and suspected small intestinal bacterial overgrowth: a pilot study
Background/aim: This study aimed to identify small intestinal bacterial overgrowth (SIBO) in children and adolescents with persistent symptoms of duodenogastric reflux disease (DGRD). Materials and methods: Patients aged 5–18 years who were diagnosed with DGRD between 2021 and 2023 were identified. Patients with two or more of 10 symptoms suggestive of SIBO (nausea, vomiting, weight loss, diarrhea, fatigue, joint pain, bloating, depression, acne rosacea, malnutrition) underwent lactulose hydrogen breath testing (LHBT). Results: A total of 112 patients with DGRD were identified. Seven patients who could not be reached via the telemedicine method were excluded from the study. LHBT was not performed for 76 patients because they had one or fewer symptoms and nine patients did not want to participate in the study. Twenty children suspected of having SIBO were invited to the hospital. The most common SIBO symptoms in these patients were fatigue, nausea, and depression. SIBO positivity was assessed in two patients who exhibited an increase of ≥20 ppm in breath hydrogen measurements up to the 90th minute following basal breath tests and the ingestion of 15 mL of lactulose. Two patients diagnosed as having SIBO had normal control LHBT values after two doses of 10 mg/kg/day rifaximin treatment. Of the 17 patients with negative LHBT results, 12 received empirical rifaximin treatment (10 mg/kg twice daily) due to clinical symptoms suggestive of SIBO, and clinical improvement was achieved in 10 patients. Eighty-five percent of patients who received rifaximin experienced symptom normalization. Conclusion: SIBO should be considered in children and adolescents with DGRD who have persistent symptoms, given that dysmotility is a common etiological factor.
- 15 October 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (5) , 1462-1469
Open AccessLactulose hydrogen breath test findings in children and adolescents with duodenogastric reflux and suspected small intestinal bacterial overgrowth: a pilot study
Background/aim: This study aimed to identify small intestinal bacterial overgrowth (SIBO) in children and adolescents with persistent symptoms of duodenogastric reflux disease (DGRD). Materials and methods: Patients aged 5–18 years who were diagnosed with DGRD between 2021 and 2023 were identified. Patients with two or more of 10 symptoms suggestive of SIBO (nausea, vomiting, weight loss, diarrhea, fatigue, joint pain, bloating, depression, acne rosacea, malnutrition) underwent lactulose hydrogen breath testing (LHBT). Results: A total of 112 patients with DGRD were identified. Seven patients who could not be reached via the telemedicine method were excluded from the study. LHBT was not performed for 76 patients because they had one or fewer symptoms and nine patients did not want to participate in the study. Twenty children suspected of having SIBO were invited to the hospital. The most common SIBO symptoms in these patients were fatigue, nausea, and depression. SIBO positivity was assessed in two patients who exhibited an increase of ≥20 ppm in breath hydrogen measurements up to the 90th minute following basal breath tests and the ingestion of 15 mL of lactulose. Two patients diagnosed as having SIBO had normal control LHBT values after two doses of 10 mg/kg/day rifaximin treatment. Of the 17 patients with negative LHBT results, 12 received empirical rifaximin treatment (10 mg/kg twice daily) due to clinical symptoms suggestive of SIBO, and clinical improvement was achieved in 10 patients. Eighty-five percent of patients who received rifaximin experienced symptom normalization. Conclusion: SIBO should be considered in children and adolescents with DGRD who have persistent symptoms, given that dysmotility is a common etiological factor.
- Open Access
- 1 September 2025
- Published by Association of Pediatric Specialization Academy in Pediatric Academic Case Reports
- Vol. 4 (3) , 63-66
Rare Complications of Blunt Thoracic Trauma: Pulmonary Edema and Late Ventricular Septal Defect
It has been reported that ventricular septal aneurysm and ventricular septal defect (VSD) may rarely develop after blunt thoracic trauma. This case report presents a pediatric case that developed VSD in the follow-up after an in-vehicle traffic accident. A 15-month-old patient had an in-vehicle traffic accident; since no additional problem was detected, he was discharged after a short follow-up. The patient was admitted to the hospital with respiratory distress five days after the trauma, with the symptoms of tachypnea and a 2/6 systolic murmur in the pulmonary focus. In echocardiography, the interventricular septum was intact, sASD and pulmonary hypertension secondary to lung contusion were present. He was transferred to the pediatric intensive care unit and intubated on the sixth day; adrenaline and milrinone were started due to hypotension. On the seventh day, echocardiography revealed a 7 mm VSD with a left-to-right shunt in the apical muscular region, and interventricular septal hypertrophy was detected. In angiography, the right ventricle was filled with two muscular defects of 4.2 mm in the apical region on the interventricular septum and the area near the middle. Direct and indirect mechanisms are well defined in the literature, and our patient's VSD occurred due to a delayed inflammatory response due to liquefaction necrosis following myocardial damage. Similar to the literature, apical muscular VSD was detected in your patient. The patient is followed closely without surgical intervention in the 11th month of follow-up. It should be kept in mind that secondary VSD may develop within days after blunt chest trauma.
- 1 September 2025
- Published by Association of Pediatric Specialization Academy in Pediatric Academic Case Reports
- Vol. 4 (3) , 63-66
Open AccessRare Complications of Blunt Thoracic Trauma: Pulmonary Edema and Late Ventricular Septal Defect
It has been reported that ventricular septal aneurysm and ventricular septal defect (VSD) may rarely develop after blunt thoracic trauma. This case report presents a pediatric case that developed VSD in the follow-up after an in-vehicle traffic accident. A 15-month-old patient had an in-vehicle traffic accident; since no additional problem was detected, he was discharged after a short follow-up. The patient was admitted to the hospital with respiratory distress five days after the trauma, with the symptoms of tachypnea and a 2/6 systolic murmur in the pulmonary focus. In echocardiography, the interventricular septum was intact, sASD and pulmonary hypertension secondary to lung contusion were present. He was transferred to the pediatric intensive care unit and intubated on the sixth day; adrenaline and milrinone were started due to hypotension. On the seventh day, echocardiography revealed a 7 mm VSD with a left-to-right shunt in the apical muscular region, and interventricular septal hypertrophy was detected. In angiography, the right ventricle was filled with two muscular defects of 4.2 mm in the apical region on the interventricular septum and the area near the middle. Direct and indirect mechanisms are well defined in the literature, and our patient's VSD occurred due to a delayed inflammatory response due to liquefaction necrosis following myocardial damage. Similar to the literature, apical muscular VSD was detected in your patient. The patient is followed closely without surgical intervention in the 11th month of follow-up. It should be kept in mind that secondary VSD may develop within days after blunt chest trauma.
- 16 September 2024
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (7) , e14853
Is Liver Transplantation Alone an Effective Treatment for Homozygotic Familial Hypercholesterolemia in Children?
Aim: To examine the long‐term results and treatment effectiveness of liver transplantation (LT) in the treatment of homozygous familial hypercholesterolemia (HoFH) in children and adolescents.Method: Patients who underwent LT due to HoFH between 2007 and 2023 were included in the study. The patients' demographic data, clinical findings, preoperative and postoperative laboratory examinations, transplantation complications, and postoperative disease courses were evaluated.Results: There were five boys with an average age of 6.2 (median: 6, range 4–10) years in the study. The average total cholesterol level of the patients before transplantation was 923 (median: 950, range: 780–1002) mg/dL and the average LDL‐cholesterol level was 864 (median: 852, range: 770–957) mg/dL. No patients died of transplant‐related complications. After an average follow‐up of 9.2 (median: 9, range: 1.5–16) years, the average total cholesterol level of the patients was 197 (median: 164, range: 137–359) mg/dL, and the average LDL‐cholesterol level was 138 (median: 92, range: 85–313) mg/dL. Four (80%) patients developed atherosclerotic cardiovascular disease during follow‐up, and two (40%) died of this cause.Conclusion: LT in the treatment of HoFH did not help our patients reach the target LDL‐cholesterol level after transplantation and did not prevent the development of cardiovascular disease. Therefore, LT alone is not curative in the treatment of HoFH.
- 16 September 2024
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (7) , e14853
Is Liver Transplantation Alone an Effective Treatment for Homozygotic Familial Hypercholesterolemia in Children?
Aim: To examine the long‐term results and treatment effectiveness of liver transplantation (LT) in the treatment of homozygous familial hypercholesterolemia (HoFH) in children and adolescents.Method: Patients who underwent LT due to HoFH between 2007 and 2023 were included in the study. The patients' demographic data, clinical findings, preoperative and postoperative laboratory examinations, transplantation complications, and postoperative disease courses were evaluated.Results: There were five boys with an average age of 6.2 (median: 6, range 4–10) years in the study. The average total cholesterol level of the patients before transplantation was 923 (median: 950, range: 780–1002) mg/dL and the average LDL‐cholesterol level was 864 (median: 852, range: 770–957) mg/dL. No patients died of transplant‐related complications. After an average follow‐up of 9.2 (median: 9, range: 1.5–16) years, the average total cholesterol level of the patients was 197 (median: 164, range: 137–359) mg/dL, and the average LDL‐cholesterol level was 138 (median: 92, range: 85–313) mg/dL. Four (80%) patients developed atherosclerotic cardiovascular disease during follow‐up, and two (40%) died of this cause.Conclusion: LT in the treatment of HoFH did not help our patients reach the target LDL‐cholesterol level after transplantation and did not prevent the development of cardiovascular disease. Therefore, LT alone is not curative in the treatment of HoFH.